Investigator sites log: Pappas-PT

Project: US 5,556,418 (Panagiotis T. Pappas, "Method and Apparatus for Pulsed Magnetic Induction", 1996), the device later sold as PAP-IMI / Papimi.

Run log

• 2026-10-04 (run 1, first run; no earlier sites.md). Chrome (claude-in-chrome) used for all searching and browsing; public PDFs and pages found in Chrome were then saved with curl into research/files/. Web time: about 6 min of the 10 min cap (date +%s start 1791141971, last web call about +364 s). Stopped early on purpose with enough leads for review; the "not reached" rows below are where the next run starts.

Sites

Keywords tried

(Run 1, 2026-10-04, all in Chrome unless noted) 1. Google Patents: US5556418A (patent page) 2. Google Patents: inventor:(Panagiotis Pappas) 3. Google Patents: inventor:(Pappas Panagiotis) 4. Google: "Pappas" PAPIMI "pulsed magnetic induction" 5. Google: Seattle Times 2007 Papimi device FDA Pappas 6. Google: "P. T. Pappas" plasma arc oscillation "negative resistance" OR Einsiedeln OR IECEC 1991 7. Google: Pappas "Nuovo Cimento" 1983 Ampere force Biot-Savart Lorentz 8. Google: "PAP-IMI" OR Papimi study pubmed OR trial OR "case reports" 9. Google Patents (curl): EP0648140B1, US20060220648A1, DE102007030325A1, RU2126278C1, WO1994001176A1, US5068039A, US5239442A, EP0402552A1, GR20180200149U 10. Google: "Energy Creation in Electrical Sparks" Pappas 11. Natural Philosophy Wiki: Panos_Pappas; Energy_Creation_in_Electrical_Sparks_and_Discharges:_Theory_and_Direct_Experimental_Evidence 12. Google: "PAP-IMI" FDA "import alert" OR "warning letter" OR IDE 13. Google: "Παναγιώτης Πάππας" PAPIMI φυσικός 14. Google: Pappas Vysotskii OR Kornilova PAP-IMI transmutation OR "cell growth energy" 15. Google: "920200309" OR "GR 920200309" Pappas patent (one hit only: the US patent itself) 16. Espacenet: in="Pappas Panagiotis" 17. Google Scholar: author:"PT Pappas" 18. Google: "PAP-IMI" OR "PAPIMI" court OR lawsuit OR "medical board" OR indictment 19. PubMed E-utilities (curl): PAPIMI OR PAP-IMI OR "PAP ion magnetic"; efetch 11913824

Not yet tried (next run): "GR920100309"; "Πάππας" "μαγνητική επαγωγή"; "Pappas" "Langmuir" plasma oscillation 1925 arc; "Tesla Symposium" 1990 Pappas "Energy Generation Phenomenon"; "Einsiedeln" 1989 "Freie Energie" Pappas (German); "Pulse Dynamics" Papimi; "Bio-Electrodynamics" Athens; "Em-Probe" Inc; "Jorge Cure" ions remote action; "Harry Eichler" Pappas; "Wallach" PAP-IMI court; "Pappas" ICCF-7 "Electrically induced fusion in the living cell"; Moyssides Pappas Ampère; "Papimi" seizures OR "wound healing" case; Efthimiadou PAPIMI tomato.

Leads for review

Priority 1: the inventor's own work

1. Patent family of US 5,556,418 [web] https://patents.google.com/patent/US5556418A/en. Priority 10 Jul 1992. Members: WO 94/01176 (PCT/US93/06616), EP 0648140 B1 (granted 31 Jan 2001; no opposition filed), DE 69329908, ES 2154271 T3, AT, DK, JP, KR, CA 2139843, BR 9306710, AU 46776/93, RU 2126278 C1 (24 claims; lapsed for non-payment, effective 9 Jul 2011), and Greek GR920100309A (Espacenet, published 31 Mar 1994). One WO listing also names "Em-Probe, Inc." as an assignee. The US patent had all three maintenance fees paid (1999, 2004, 2007) and expired in 2013. Bears on: every claim. The EP and RU texts can be compared with the US text for changed numbers or added data. The RU abstract states the purpose as "therapeutic curing of malignant tumors" and says the plasma "generates characteristic radio frequency which is resonant to treated object" (claims 2 and 4).
2. Greek priority title (Espacenet, GR920100309A) [web]: "Method and device for the powerful induction of the ions and for the selective activation of the atoms by natural resonance plasma oscillations". The Greek abstract says charges are moved "from afar, instantaneously and without breakdown of the atmospheric air", with amplification of the available electric potential and no electrical contact, so that selected chemical reactions can be triggered. Bears on: claims 1, 3 and 4. The number differs from "920200309" printed in the US patent; the US number may be a misprint.
3. Earlier arc and spark patents by Pappas [web] (Espacenet, Google Patents): GR2000017Y (priority 9 Feb 1988); EP 0402552 A1 "High ionisation lightning conductor with an oscillating high-voltage converter" (priority 12 Jun 1989; capacitor and coil oscillatory circuit fired by a spark gap); GR1000007B (1990) "Lightning arrester of high ionization and convertor of high oscillatory tension"; GR1000132B (1991) "Composite lightning protector of high ionization and attenuation". Bears on: claim 1. These are the "P.T. Pappas, patents, 1988, 1989, 1991" on arcs and negative resistance that his later writings cite: the spark-gap and LC oscillator design existed before the medical use.
4. 1989 co-invention "Method and device for dispersing / removing ions by remote action" [web] https://patents.google.com/patent/US5068039A/en. US 5,068,039 (1991) and US 5,239,442 (1993), inventors Jorge Cure, Panagiotis T. Pappas, Harry Eichler; also WO 91/04102, AU 6421390A, Greek priority GR890100595 (20 Sep 1989). Abstract: remote-action transport of ions inside biological matter; "ideal in applying Nordenstrom's method". Bears on: claims 3 and 5. This is the direct precursor of the 1992 filing and adds two co-inventors not named in the project documents.
5. Later NMR/EPR patent family [web] https://patents.google.com/patent/US20060220648A1/en. US 2006/0220648 A1 became US 7,151,372 B2. Priority 30 Jun 2003, very wide family (WO, EP, CN, JP, KR, RU, AU, CA, NO, IL and more), plus GR1006848B (2010) and CY1109665T1 (2014). Abstract: a pulsed and damped magnetic field from one inductor gives "a wide nuclear NMR and electronic EPR multiple-resonance" with no static field. US maintenance fees paid through the 12th year (2018). Bears on: claim 4. Here Pappas reframes the "resonant selective absorption" idea as NMR/EPR resonance.
6. "Pappas' Physiology of the Cell and its Atomic Energy" (Athens, 24 Mar 2006, 67 pp) [web] (file research/files/Pappas-Physiology-of-the-Cell-ralf-kollinger.pdf). It includes the 2 Mar 2002 Starnberg talk "PAPIMI - The Spark of Life". He claims instantaneous power ">1 Giga Watts", a rise time of "some hundreds of nanoseconds", and an active/pause ratio of 1e-7. He presents an oscillogram he reads as "Nuclear Magnetic Resonance Emitted Echoes". He gives a session of "888 magnetic nanopulses at about 80 Joules each" over about 30 cm x 30 cm, and states the CE 0120 (SGS UK), GOSSTANDART and Mexico licences. The cell is described as an "(ATP) controlled microscopic Nuclear Reactor" (Na + O -> K transmutation). Bears on: claims 1, 2, 4 and 5. These are later numbers the inventor gives for the same device.
7. Pappas letter, New Energy News vol 6 no 2, June 1998 [web] (file NEN-1998-06-N199806.pdf, p.28). He writes that the PAP-IMI "triggers biological transmutations", that he "managed to do C to Fe", and that "PAP IMI also produces 20% excess heat on the probe alone". He says it produced water, with energies "in the range of 30 Kev". He mentions an ICCF-7 paper, "Electrically induced fusion in the living cell". The editor notes Pappas was "working with M.D.'s from UCLA in Santa Monica". Bears on: claims 1 and 4. This is the inventor's own statement of excess energy at the probe.
8. Physics publications [web] (Google Scholar, Natural Philosophy Wiki). Pappas, "The original Ampère force and Biot-Savart and Lorentz forces", Nuovo Cimento B 76, 189 (1983), cited by 151. Pappas & Moyssides, Phys. Lett. A 111, 193 (1985). Moyssides & Pappas, "Rigorous quantitative test of Biot-Savart-Lorentz forces", J. Appl. Phys. (1986), an experiment at the National Technical University of Athens. Nuovo Cimento papers on six-dimensional physics (1978-1982). Conference abstracts: 1988 "Cardinal Law of Electrodynamics... and the Tesla Magnifying Effect"; 1989 "Non Relativistic Forces on Antennas"; 1990 "Energy Generation Phenomenon: Lab to Star and Galaxy Generation"; 1991 IECEC "Energy Creation in Electrical Sparks and Discharges: Theory and Direct Experimental Evidence" (vol. 4, pp. 416-423); 1999 "K-Na-K Nuclear Transmutations Inside the Living Cell". Bears on: claim 1. The 1991 IECEC paper is the source the patent cites for the 10-100x gain and has not been obtained yet. Pappas's Ampère-force (cardinal law) work is his stated theoretical base for energy creation in sparks.
9. Inventor's own lectures [web] (Greek Google results, not opened): YouTube "Παναγιώτης Παππάς (διάλογοι χωρίς Stop) 1999" (30 min) and "Διογένειος Λέσχη 24-1-2014 Δρ. Παναγιώτης Παππάς" (64 min). Also a 2018 radio programme with G. Lekakis (via arxeion-politismou.gr). Bears on: all claims.
10. GR20180200149U (2018) "Earth unbalance device - free energy generation from zero" [web], by Panagiotis Theochari Pappas with Theocharis and Eleftherios Pappas: a 134 m closed loop driven by a square-wave pulse generator. Bears on: claim 1. Pappas kept working on energy-creation claims until late in life.

Priority 2: supporting information by others

1. Viti et al. 2023, Int J Environ Res Public Health 20(5):3934 (PMC10001461) [web] https://pmc.ncbi.nlm.nih.gov/articles/PMC10001461/. Single-blind, randomized, sham-controlled pilot, n = 32 (17 PAPIMI, 15 sham), chronic musculoskeletal pain. HRV time-domain indices and HF rose after one PAPIMI session; no change after sham. Authors: Centro Fisioterapico Apuano (Lucca) and University of Florence. They declare no conflict and no external funding. Bears on: claim 5 (physiological effect). It measures autonomic response, not transmembrane potential.
2. Viti et al. 2025, Healthcare (Basel) (PMC12385873) [web]. Single-arm pilot, n = 30, one session. Pain score fell (p < 0.001; median 2 points), and RMSSD and HF power rose. No sham arm. Bears on: claim 5. The papimi.com company site promotes it as "Clinical Trial Confirms..." (interested party).
3. Keilani et al. 2025, Wien Klin Wochenschr (PMC12534222) [web]. Medical University of Vienna. Randomized, single-blinded, placebo-controlled pilot, n = 20, post-COVID fatigue, Papimi Delta, 10 sessions. Improvements in the 6-minute walk, fatigue scales and other measures. The authors declare no competing interests. Bears on: claim 5.
4. Independent descriptions of the waveform (from the papers above, citing the manufacturer) [web]. Capacitor discharged "through a plasma chamber (spark gap)" into a spiral coil. Up to 40 kV and "peak currents of several 10 kA". About 60 J per pulse (Viti) or 96 J (Keilani). 50-150 mT. Base frequency about 240 kHz. Pulse about 50 us. 1-8 Hz repetition. Keilani: "In the maxima and minima of the damped oscillation, high-frequency oscillation peaks in the megahertz to gigahertz range arise." Bears on: claims 2 and 3. This is the same burst-at-extrema waveform as FIG. 2-3 of the patent, now with numbers the patent lacks (voltage, current, energy). The figures are the manufacturer's (Pulse Dynamics), not independent measurements.
5. Viti 2023 cites earlier PAPIMI human reports (refs 40-42): refractory seizures, skin wound healing and fatigue syndrome, single-subject designs. Not yet retrieved. Bears on: claim 5.
6. Seattle Times 2007 report of supporters: Pappas treated C. Wallach's chronic back pain and "both claimed the treatment a success"; investigator testimonials and a paper by Dr Shri Kant Mishra (FDA EIR, exhibit 23) [web]. These are the interested parties' own claims and are recorded as such.
7. Karampatsou memoriam (2026) [web]. She reports doctors from Europe, America and Asia presenting PAPIMI results at a conference in Salzburg, and PAPIMI in use in a hospital in Cuba, in Vietnam with acupuncture, and in Swiss clinics. She has been a collaborator since 1996 (interested party). No study is cited in the memoriam.

Priority 3: closely related work

1. Citing patents (13) [web] (Google Patents "Cited by"). Healing Machines WO 98/57704 and US 5,908,444 (complex-frequency pulsed EM generator). Biofields ApS US 6,561,968. Pulsartec S.L. EP 2062614 A1 "Method and device for impulse induction" (2007). Horkel DE 10 2007 030325 A1 (2007): a near copy of the PAP-IMI layout (plugs, inlet filter, voltage regulator, timer, storage capacitor, discharge element), whose Google record lists "Pappas; Panagiotis T." among the original assignees; it lapsed for non-payment in 2010. Weth WO 2010/043190 "Pulse wave generator". Brilliant Light Power WO 2016/182600 (plasma UV power generation). Bears on: claims 1-3. Others built pulsed spark-gap induction devices on the same pattern.
2. Prior art cited in the patent [web]: Czerlinski US 4,369,345 (selective localized hyperthermia), Gordon US 4,622,953, and Liboff et al. US 5,160,591 (Life Resonances: "regulating transmembrane ion movement utilizing selective harmonic frequencies", i.e. ion cyclotron resonance). Bears on: claim 4. Liboff's ion-resonance concept is the nearest mainstream-adjacent version of "selective resonant absorption".
3. Biological transmutation literature linked to Pappas: E. Y. Moawad (2013) Univ. J. Med. Sci. 1(2):27-35 [web] (cites Pappas, "PAP-IMI Cases Reports", 1990-1998, and Pappas, "Electrically Induced Nuclear Fusion", Journal of New Energy). V. I. Vysotskii and A. A. Kornilova (biological transmutation) are cited alongside. Kervran effect. Bears on: claim 4, in Pappas's later version.
4. Nordenstrom's electrochemical cancer therapy (named in the patent and in the 1989 Cure-Pappas-Eichler patent). Not searched this run.
5. Nanopulse and electroporation devices that Pappas himself lists as "connections": surgical diathermy, defibrillators, electroporators, and Rife, Lakhovsky and Priore devices (Physiology PDF, p.4).

Priority 4: the historical record

1. FDA 510(k) for the "Pap Ion magnetic inductor", submitted 6 Nov 1995, not cleared because it needed clinical data that were not available (FDA EIR p.2; Seattle Times timeline "1995 NOVEMBER: The FDA denies a request to sell and market") [web].
2. FDA Establishment Inspection Report, Bio-Energy Services Inc., Tarzana CA, inspections 21, 22 and 26 Aug and 10 Sep 2002 (17 pp; FEI 3003668912) [web] (file seattletimes-2007-FDA-EIR-papimi.pdf; scanned, read by OCR). Findings: sponsor-investigator C. Wallach; 37 study sites in at least 12 states; 14-item FDA-483; study terminated by BioMed IRB on 7 Jun 2002 and not stopped; units imported from Athens declared as "plant and seed germinator" (broker engaged 15 Oct 1999); manufacturer named as a Pappas company ("Z Electrodynamics" production, with an R&D sister company); model 600P; CE marked, without UL or CSA; an infant with rhabdomyosarcoma treated about 29 times; $60 per half-hour session. The inspector wrote that "the science behind the device is not clear". Bears on: the history of the claims and the absence of controlled efficacy data before 2023.
3. FDA letter to Panos Pappas PhD, Chatsworth CA, dated 10 Jun 2005 (CDRH Bioresearch Monitoring, M. E. Marcarelli) [web] (file seattletimes-2007-11-19-FDA-letter-papimi.pdf). The FDA found the device a significant-risk device ("Class III non-heating diathermy", PMA required). Its reasons: "capable of delivering 100 watts at 2 apps (2 seconds x 50 Joules) of energy for every two pulses"; animal studies with "2 Wistar rat deaths and one case of tremor"; human adverse events "2 cases of tachycardia and one fatal myocardial infarction during treatment". The device was declared adulterated. Bears on: claim 3 (FDA's energy figure per pulse, from an interested regulator) and the record.
4. FDA Warning Letter, 24 Jun 2003, to Dr C. Jones Jaye, LifeWorks Wellness Center, Clearwater FL (device name redacted; CIRCARE files it as PAP-IMI) [web]: consent and IRB failures; at least 50 subjects treated before IRB approval (24 Sep 2002).
5. FDA Import Alert 89-08 [web]: "PAP-IMI Ion Magnetic Conductor Device", importer of record Bio-Energy Services (added 16 Sep 2009, note dated 1/13/2003). Greek firm "BioElectroDynamics", Athens, added 20 Dec 2018.
6. Seattle Times investigation, 19 Nov 2007 (C. Willmsen and M. J. Berens) [web]: 89 units in the US by state; deaths linked by the paper and regulators. Pappas is quoted: the machine "is absolutely safe", "can cure cancer and AIDS", and "It goes beyond known human knowledge." Former staff accounts. This is the newspaper's characterization; the FDA and California officials quoted are interested regulators.
7. California 2005 judgment against Gerald Allen Anderson / Bio-Energy Services (later Biophotonix): barred from false or misleading claims; $2,750 penalty plus $7,000 costs [web] (Quackwatch Casewatch, a site with an anti-quackery stance).
8. Health Canada advisory, 28 Dec 2007 and border seizure order (via Wikipedia refs; not checked directly).
9. Leisner et al. 2002, J Vet Med A 49(1):33-7, PMID 11913824 (Hebrew University, Koret School of Veterinary Medicine) [web]. Rat ulnar fracture model; the PAP-IMI group healed more slowly on radiographs and had more fibrous callus. "The results of this study do not support the claim that PEMF generated by the PAP-IMI stimulate osteogenesis." An independent controlled animal test with a negative result.
10. Later regulatory status: the device is CE marked in the EU (Pappas: CE 0120 via SGS UK). Since at least 2023 it has been made by Pulse Dynamics Ltd (Pipinou 1 & Souliou, 17342 Agios Dimitrios, Greece), and university groups in Italy and Austria use it in published trials. The record did not go dark: after the 2005-2009 US ban it continued in Europe and elsewhere.
11. Death of the inventor: Greek Facebook posts (G. Kasimatis) give 11 May 2026; the Arxeion Politismou memoriam of 11-12 Jun 2026 says his two children, both physicists, one a university professor, continue the work [web]. Single-source date; to be confirmed.
12. Earlier academic post: a 2009 Greek blog calls him a "professor" at TEI Piraeus (in sceptical quotation marks) [web] (Google snippet only, not opened).